![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
B Zimmerli, J Valantinas and PJ Meier
Department of Medicine, University Hospital, Zurich, Switzerland.
To test the hypothesis of broad specificity of the hepatocellular bile acid uptake system(s) we investigated the kinetics and substrate specificity of Na+-dependent taurocholate uptake in basolateral (sinusoidal) rat liver plasma membrane vesicles in the presence and absence of bovine serum albumin. Bovine serum albumin selectively stimulated the Na+-dependent portion of taurocholate uptake and decreased its apparent Km from 46 +/- 6 to 17 +/- 3 microM, whereas it had no effect on Vmax (4.2 +/- 0.2 nmol.mg-1.min-1). Based on complementary analysis by Dixon- and Cornish-Bowden-plots the following compounds were identified as competitive inhibitors of Na+-dependent taurocholate uptake: cholate (Ki = 140 +/- 30 microM); taurochenodeoxycholate (Ki = 9 +/- 3 microM); chenodeoxycholate (Ki = 53 +/- 6 microM); progesterone (Ki = 110 +/- 30 microM); 17-beta- estradiol-3-sulfate (Ki = 28 +/- 4 microM); bumetanide (Ki = 440 +/- 85 microns); furosemide (Ki = 460 +/- 140 microM); verapamil (Ki = 65 +/- 35 microM); and phalloidin (Ki = 850 +/- 350 microM). In contrast, noncompetitive inhibition was found with bromosulfophthalein (Ki = 12 +/- 2 microM), cyclosporin A (Ki = 3 +/- 1 microM) and 4,4'- diisothiocyano-2,2'-disulfonic acid stilbene (Ki = 45 +/- 7 microM). These results support the concept of multispecificity of the Na+- dependent basolateral bile acid uptake system with respect to different bile acids and drugs. In addition, the findings provide further evidence for bile acids and bromosulfophthalein being taken up into rat hepatocytes by different transport systems, thus supporting the assumption of multiple basolateral organic anion "carriers" with distinct, yet partially overlapping substrate specificities.
This article has been cited by other articles:
|
|
 |
|
  F. R. Simon, J. Fortune, M. Iwahashi, I. Qadri, and E. Sutherland Multihormonal regulation of hepatic sinusoidal Ntcp gene expression Am J Physiol Gastrointest Liver Physiol, October 1, 2004; 287(4): G782 - G794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kouzuki, H. Suzuki, B. Stieger, P. J. Meier, and Y. Sugiyama Characterization of the Transport Properties of Organic Anion Transporting Polypeptide 1 (oatp1) and Na+/Taurocholate Cotransporting Polypeptide (Ntcp): Comparative Studies on the Inhibitory Effect of their Possible Substrates in Hepatocytes and cDNA-Transfected COS-7 Cells J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 505 - 511. [Abstract] [Full Text]
|
|
|
|
|
|
R. B. Kim, B. Leake, M. Cvetkovic, M. M. Roden, J. Nadeau, A. Walubo, and G. R. Wilkinson Modulation by Drugs of Human Hepatic Sodium-Dependent Bile Acid Transporter (Sodium Taurocholate Cotransporting Polypeptide) Activity J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1204 - 1209. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. Kramer, S. Stengelin, K.-H. Baringhaus, A. Enhsen, H. Heuer, W. Becker, D. Corsiero, F. Girbig, R. Noll, and C. Weyland Substrate specificity of the ileal and the hepatic Na+/bile acid cotransporters of the rabbit. I. Transport studies with membrane vesicles and cell lines expressing the cloned transporters J. Lipid Res., September 1, 1999; 40(9): 1604 - 1617. [Abstract] [Full Text]
|
|
|
|
|
|
A. I. Galán, M. E. Muñoz, and R. Jiménez S-Adenosylmethionine Protects Against Cyclosporin A-Induced Alterations in Rat Liver Plasma Membrane Fluidity and Functions J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 774 - 781. [Abstract] [Full Text]
|
|
|
|
|
|
X. Liu, E. L. LeCluyse, K. R. Brouwer, R. M. Lightfoot, J. I. Lee, and K. L. R. Brouwer Use of Ca2+ Modulation to Evaluate Biliary Excretion in Sandwich-Cultured Rat Hepatocytes J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1592 - 1599. [Abstract] [Full Text]
|
|
|
|
|
|
H. Kouzuki, H. Suzuki, K. Ito, R. Ohashi, and Y. Sugiyama Contribution of Sodium Taurocholate Co-Transporting Polypeptide to the Uptake of Its Possible Substrates Into Rat Hepatocytes J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 1043 - 1050. [Abstract] [Full Text]
|
|
|
|
|
|
A. Wolf, U. Schramm, A. Fahr, L. Aicher, A. Cordier, W. E. Trommer, and G. Fricker Hepatocellular Effects of Cyclosporine A and its Derivative SDZ IMM 125 in Vitro J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 817 - 825. [Abstract] [Full Text]
|
|
|
|
|
|
A. Schroeder, U. Eckhardt, B. Stieger, R. Tynes, C. D. Schteingart, A. F. Hofmann, P. J. Meier, and B. Hagenbuch Substrate specificity of the rat liver Na+-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells Am J Physiol Gastrointest Liver Physiol, February 1, 1998; 274(2): G370 - G375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Craddock, M. W. Love, R. W. Daniel, L. C. Kirby, H. C. Walters, M. H. Wong, and P. A. Dawson Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter Am J Physiol Gastrointest Liver Physiol, January 1, 1998; 274(1): G157 - G169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamada, K. Niinuma, M. Lemaire, T. Terasaki, and Y. Sugiyama CARRIER-MEDIATED HEPATIC UPTAKE OF THE CATIONIC CYCLOPEPTIDE, OCTREOTIDE, IN RATS. Comparison between In Vivo and In Vitro Drug Metab. Dispos., May 1, 1997; 25(5): 536 - 543. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
